ID: ALA572275

Max Phase: Preclinical

Molecular Formula: C9H12IN2O8P

Molecular Weight: 434.08

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)cc1[125I]

Standard InChI:  InChI=1S/C9H12IN2O8P/c10-4-2-12(9(15)11-8(4)14)7-1-5(13)6(20-7)3-19-21(16,17)18/h2,5-7,13H,1,3H2,(H,11,14,15)(H2,16,17,18)/t5-,6+,7+/m0/s1/i10-2

Standard InChI Key:  WXFYBFRZROJDLL-XCAQJPMGSA-N

Associated Targets(Human)

Testis-specific androgen-binding protein 320 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serum albumin 2651 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serum 1292 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Serum albumin 11 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serum albumin 6 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 434.08Molecular Weight (Monoisotopic): 433.9376AlogP: -1.10#Rotatable Bonds: 4
Polar Surface Area: 151.08Molecular Species: ACIDHBA: 7HBD: 4
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.23CX Basic pKa: CX LogP: -0.65CX LogD: -4.21
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.34Np Likeness Score: 0.89

References

1. Kortylewicz ZP, Nearman J, Baranowska-Kortylewicz J..  (2009)  Radiolabeled 5-iodo-3'-O-(17beta-succinyl-5alpha-androstan-3-one)-2'-deoxyuridine and its 5'-monophosphate for imaging and therapy of androgen receptor-positive cancers: synthesis and biological evaluation.,  52  (16): [PMID:19653647] [10.1021/jm9005803]

Source